{"transactions":[{"id":2078195,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121358,"kind":"person","name":"Ross Douglas T.","position":1,"cik":"0001808413","reported_name":"Ross Douglas T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CSO"}}],"security":"Common Stock, no par value","published_at":"2022-12-22T18:57:14.000Z","date":"2022-12-21","kind":"grant","acquired":true,"shares":213797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock units will vest as follows: (i) one-third on January 31, 2023, (ii) one-third on February 28, 2023, and (ii) one-third on March 31, 2023 (each such date, a \"Vesting Date\"), in each case, subject to the Reporting Person's continuous service as a consultant on each applicable Vesting Date."}],"balance_after":234114,"source":{"system":"sec-edgar","filing":"0001493152-22-036367","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808413/000149315222036367/ownership.xml","form_type":"4"}},{"id":2080362,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121358,"kind":"person","name":"Ross Douglas T.","position":1,"cik":"0001808413","reported_name":"Ross Douglas T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CSO."}}],"security":"Option to Purchase Common Stock","published_at":"2022-12-20T16:05:38.000Z","date":"2022-12-16","kind":"disposition_to_issuer","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022."}],"balance_after":0,"derivative":{"exercise_price":1.15,"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-22-035991","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808413/000149315222035991/ownership.xml","form_type":"4"}},{"id":2080361,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121358,"kind":"person","name":"Ross Douglas T.","position":1,"cik":"0001808413","reported_name":"Ross Douglas T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CSO."}}],"security":"Option to Purchase Common Stock","published_at":"2022-12-20T16:05:38.000Z","date":"2022-12-16","kind":"disposition_to_issuer","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022."}],"balance_after":0,"derivative":{"exercise_price":1.15,"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-22-035991","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808413/000149315222035991/ownership.xml","form_type":"4"}},{"id":2080360,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121358,"kind":"person","name":"Ross Douglas T.","position":1,"cik":"0001808413","reported_name":"Ross Douglas T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CSO."}}],"security":"Option to Purchase Common Stock","published_at":"2022-12-20T16:05:38.000Z","date":"2022-12-16","kind":"disposition_to_issuer","acquired":false,"shares":143438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022."}],"balance_after":111562,"derivative":{"exercise_price":5.34,"underlying":"Common Stock","underlying_shares":143438},"source":{"system":"sec-edgar","filing":"0001493152-22-035991","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808413/000149315222035991/ownership.xml","form_type":"4"}},{"id":2080359,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121358,"kind":"person","name":"Ross Douglas T.","position":1,"cik":"0001808413","reported_name":"Ross Douglas T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CSO."}}],"security":"Option to Purchase Common Stock","published_at":"2022-12-20T16:05:38.000Z","date":"2022-12-16","kind":"disposition_to_issuer","acquired":false,"shares":83334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022."}],"balance_after":166666,"derivative":{"exercise_price":1.93,"underlying":"Common Stock","underlying_shares":83334},"source":{"system":"sec-edgar","filing":"0001493152-22-035991","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808413/000149315222035991/ownership.xml","form_type":"4"}},{"id":2080358,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121358,"kind":"person","name":"Ross Douglas T.","position":1,"cik":"0001808413","reported_name":"Ross Douglas T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CSO."}}],"security":"Common Stock, no par value","published_at":"2022-12-20T16:05:38.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining restricted stock units immediately vested on December 16, 2022."}],"balance_after":20317,"source":{"system":"sec-edgar","filing":"0001493152-22-035991","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808413/000149315222035991/ownership.xml","form_type":"4"}},{"id":2183046,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121358,"kind":"person","name":"Ross Douglas T.","position":1,"cik":"0001808413","reported_name":"Ross Douglas T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, no par value","published_at":"2022-08-17T20:24:08.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units shall vest on January 1, 2024 based on the achievement of a pre-determined financial objective related to the Issuer's available cash."}],"balance_after":170317,"source":{"system":"sec-edgar","filing":"0001493152-22-023389","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808413/000149315222023389/ownership.xml","form_type":"4"}},{"id":2317214,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121358,"kind":"person","name":"Ross Douglas T.","position":1,"cik":"0001808413","reported_name":"Ross Douglas T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, no par value","published_at":"2022-03-28T20:00:15.000Z","date":"2022-03-25","kind":"purchase","acquired":true,"shares":15000,"price":1.4,"value":21000.0,"ownership":{"direct":true},"balance_after":20317,"source":{"system":"sec-edgar","filing":"0001493152-22-007931","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808413/000149315222007931/ownership.xml","form_type":"4"}},{"id":2329380,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121358,"kind":"person","name":"Ross Douglas T.","position":1,"cik":"0001808413","reported_name":"Ross Douglas T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2022-03-17T21:29:21.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest subject to the Issuer's achievement of pre-defined product development, regulatory and financial goals in 2022. 100% of the options will vest on December 31, 2023, if such pre-defined goals have been achieved in 2022, subject to continuous service through the vesting date."}],"balance_after":100000,"derivative":{"exercise_price":1.15,"expiration_date":"2032-03-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-22-007209","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808413/000149315222007209/ownership.xml","form_type":"4"}},{"id":2329379,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121358,"kind":"person","name":"Ross Douglas T.","position":1,"cik":"0001808413","reported_name":"Ross Douglas T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2022-03-17T21:29:21.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date."}],"balance_after":100000,"derivative":{"exercise_price":1.15,"expiration_date":"2032-03-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-22-007209","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808413/000149315222007209/ownership.xml","form_type":"4"}},{"id":2828173,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121358,"kind":"person","name":"Ross Douglas T.","position":1,"cik":"0001808413","reported_name":"Ross Douglas T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-01T16:23:45.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":255000,"price":5.34,"value":1361700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting: Twenty-five percent of the options will vest and thereby become exercisable upon completion of one year of service from the date of grant, and the balance of the options will vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, subject to his continued service as an employee on the applicable vesting date."}],"balance_after":255000,"derivative":{"exercise_price":5.34,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":255000},"source":{"system":"sec-edgar","filing":"0001493152-21-005097","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808413/000149315221005097/ownership.xml","form_type":"4"}},{"id":2945563,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":121358,"kind":"person","name":"Ross Douglas T.","position":1,"cik":"0001808413","reported_name":"Ross Douglas T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2020-12-15T06:22:09.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":5317,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's common stock were issued to the Reporting Person for the repayment of deferred compensation in lieu of cash at a price of $2.07 per share."}],"balance_after":5317,"source":{"system":"sec-edgar","filing":"0001493152-20-023593","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808413/000149315220023593/ownership.xml","form_type":"4"}}]}